MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 51 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,129,000 | +107.1% | 1,100,994 | +228.5% | 0.02% | +100.0% |
Q2 2022 | $1,994,000 | -7.7% | 335,108 | -1.9% | 0.01% | -11.1% |
Q1 2022 | $2,161,000 | +61.8% | 341,685 | 0.0% | 0.01% | +80.0% |
Q4 2021 | $1,336,000 | -19.0% | 341,685 | 0.0% | 0.01% | -28.6% |
Q3 2021 | $1,650,000 | +23.2% | 341,685 | +63.0% | 0.01% | +16.7% |
Q2 2021 | $1,339,000 | – | 209,563 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Standard LLC | 1,894,013 | $23,353,180 | 21.09% |
Newtyn Management, LLC | 1,873,694 | $23,102,647 | 5.70% |
Sio Capital Management, LLC | 288,466 | $3,556,786 | 1.10% |
Madison Avenue Partners, LP | 553,085 | $6,819,538 | 0.97% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 209,739 | $2,586 | 0.95% |
Indaba Capital Management, L.P. | 136,802 | $1,686,769 | 0.50% |
Sepio Capital, LP | 306,680 | $3,781,364 | 0.33% |
Yakira Capital Management, Inc. | 54,118 | $667,275 | 0.18% |
Centiva Capital, LP | 187,803 | $2,315,611 | 0.05% |
FIFTH LANE CAPITAL, LP | 10,929 | $134,427 | 0.05% |